InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Browse the detailed record of transactions filed by Cooper Ronald Harold Wilfred, Chief Executive Officer. Director active across 1 companies, notably Albireo Pharma, INC.. In total, 5 filings have been logged. Total volume traded: €189k. The latest transaction was filed on 22 April 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
€27,716907 shares@ €30.55794.8% of flow
Common Stock
SEC:0001209191-22-025523:0·
€80,8243,684 shares@ €21.939129.3% of flow
Common Stock
SEC:0001209191-22-004801·
€80,8243,684 shares@ €21.939113.9% of flow
Common Stock
SEC:0001209191-22-004801:0·
€195,25211,973 shares@ €16.307770.7% of flow
Common Stock
SEC:0001209191-21-056860·
€195,25211,973 shares@ €16.307733.7% of flow
Common Stock
SEC:0001209191-21-056860:0·
5 of 5 declarations
About Cooper Ronald Harold Wilfred
Ronald Harold Wilfred Cooper is the President and CEO of ALBIREO PHARMA, INC. He leads the company and is responsible for implementing the overall strategy. Ronald plays a key role in directing operations and developing new pharmaceutical products.
